<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(4)</volume><submitter>De Simone P</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>In Italy, data on long-term survivors after liver transplantation are lacking.&lt;h4>Materials and methods&lt;/h4>We conducted a hybrid design study on a cohort of 359 adult recipients who received transplants between 1996 and 2002 to identify predictors of survival and the prevalence of co-morbidities among long-term survivors.&lt;h4>Results&lt;/h4>The actuarial (95% CI) patient survival was 96% (94.6-98.3%), 69% (64.2-73.6%), 55% (49.8-59.9%), 42.8% (37.6-47.8%), and 34% (29.2-38.9%) at 1, 5, 10, 15, and 20 years, respectively. The leading causes of death were hepatitis C virus recurrence (24.6%), extrahepatic malignancies (16.9%), infection (14.4%), and hepatocellular carcinoma recurrence (14.4%). The factors associated with the survival probability were younger donor and recipie</pubmed_abstract><journal>Journal of clinical medicine</journal><pagination>1087</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10889074</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation.</pubmed_title><pmcid>PMC10889074</pmcid><pubmed_authors>Gitto S</pubmed_authors><pubmed_authors>Ducci J</pubmed_authors><pubmed_authors>Marchetti P</pubmed_authors><pubmed_authors>Campani D</pubmed_authors><pubmed_authors>Martinelli C</pubmed_authors><pubmed_authors>De Simone P</pubmed_authors><pubmed_authors>Biancofiore G</pubmed_authors><pubmed_authors>Bronzoni J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation.</name><description>&lt;h4>Background&lt;/h4>In Italy, data on long-term survivors after liver transplantation are lacking.&lt;h4>Materials and methods&lt;/h4>We conducted a hybrid design study on a cohort of 359 adult recipients who received transplants between 1996 and 2002 to identify predictors of survival and the prevalence of co-morbidities among long-term survivors.&lt;h4>Results&lt;/h4>The actuarial (95% CI) patient survival was 96% (94.6-98.3%), 69% (64.2-73.6%), 55% (49.8-59.9%), 42.8% (37.6-47.8%), and 34% (29.2-38.9%) at 1, 5, 10, 15, and 20 years, respectively. The leading causes of death were hepatitis C virus recurrence (24.6%), extrahepatic malignancies (16.9%), infection (14.4%), and hepatocellular carcinoma recurrence (14.4%). The factors associated with the survival probability were younger donor and recipie</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2025-04-19T14:49:05.525Z</modification><creation>2025-04-19T14:49:05.525Z</creation></dates><accession>S-EPMC10889074</accession><cross_references><pubmed>38398400</pubmed><doi>10.3390/jcm13041087</doi></cross_references></HashMap>